Faculty invited to develop courses on artificial intelligence and the future of work
Up to six $5,000 mini grants available
The Office of the Vice Provost for Undergraduate Affairs, through the UC Forward Program, invites applications from faculty to develop 2019-20 course offerings that address the impact of advances in artificial intelligence (AI) on the future of work.
Up to six courses will be funded with course development awards of $5,000 each. Activities are intended to promote progressive pedagogy and associated research inquiry. Coursework interactions and outcomes are anticipated to lead to future collaboration among diverse disciplines in both teaching and ancillary research opportunities in any related area of interest.
Coursework proposals are sought from all disciplines, including those not traditionally focused on AI studies.
The deadline to apply for funding is January 18, 2019, at 4 p.m.
"Think" you can get funded?
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.